PTGS2 and breast cancer: Additionally, intratumoral Tregs were demonstrated to predict worse OS in cyclooxygenase-2-positive uveal melanoma while the relationship between Foxp3+ cells and clinical outcome has been tested repeatedly in breast cancer subtypes according to estrogen receptor [25, 33, 34].